Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-003232

Director sold 2,000 shares at $242.11 ($484,220)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FARRELL PETER C Director 2025-02-05 Sale 10b5-1 −2,000 $242.11 $484,220 77,218 D
Open-market sales · 2,000 sh · avg $242.11 · $484,220
Loading xslF345X05/form4.xml…